C.RIVESIN — DEVELOPMENT AND REGISTRATION OF A MEDICINAL PRODUCT FOR HUMAN USE, FOR RARE DISEASES: TREATMENT OF INTERSTITAL CYSTITIS, FOR ITS DISTRIBUTION ON THE EUROPEAN UNION. (Q2043648): Difference between revisions
Jump to navigation
Jump to search
(BatchIngestion) |
(BatchIngestion) |
||
Property / contained in Local Administrative Unit | |||
Property / contained in Local Administrative Unit: Milano / rank | |||
Property / contained in Local Administrative Unit | |||
Property / contained in Local Administrative Unit: Milano / rank | |||
Normal rank |
Revision as of 10:11, 14 June 2023
Project Q2043648 in Italy
Language | Label | Description | Also known as |
---|---|---|---|
English | C.RIVESIN — DEVELOPMENT AND REGISTRATION OF A MEDICINAL PRODUCT FOR HUMAN USE, FOR RARE DISEASES: TREATMENT OF INTERSTITAL CYSTITIS, FOR ITS DISTRIBUTION ON THE EUROPEAN UNION. |
Project Q2043648 in Italy |
Statements
15,000.0 Euro
0 references
30,000.0 Euro
0 references
50.0 percent
0 references
18 July 2017
0 references
14 March 2018
0 references
23 October 2017
0 references
NEXTRARESEARCH SOCIETA' A RESPONSABILITA' LIMITATA
0 references
C.RIVESTIN - DEVELOPMENT AND REGISTRATION OF A MEDICINAL PRODUCT FOR HUMAN USE, FOR RARE DISEASE: TREATMENT OF INTERSTITIAL CYSTITIS, FOR ITS DISTRIBUTION ON THE EUROPEAN UNION. (Italian)
0 references
C.RIVESIN — DEVELOPMENT AND REGISTRATION OF A MEDICINAL PRODUCT FOR HUMAN USE, FOR RARE DISEASES: TREATMENT OF INTERSTITAL CYSTITIS, FOR ITS DISTRIBUTION ON THE EUROPEAN UNION. (English)
0 references
C.RIVESTIN — MISE AU POINT ET ENREGISTREMENT D’UN MÉDICAMENT À USAGE HUMAIN, POUR LES MALADIES RARES: TRAITEMENT DE LA CYSTITE INTERSTITIELLE, POUR SA DISTRIBUTION DANS L’UNION EUROPÉENNE. (French)
16 December 2021
0 references
C.RIVESTIN — ONTWIKKELING EN REGISTRATIE VAN EEN GENEESMIDDEL VOOR MENSELIJK GEBRUIK, VOOR ZELDZAME ZIEKTEN: BEHANDELING VAN INTERSTITIËLE CYSTITIS, VOOR DE VERSPREIDING ERVAN OVER DE EUROPESE UNIE. (Dutch)
23 December 2021
0 references
C.RIVESTIN – ENTWICKLUNG UND REGISTRIERUNG EINES HUMANARZNEIMITTELS FÜR SELTENE KRANKHEITEN: BEHANDLUNG INTERSTITIELLER ZYSTITIS FÜR IHRE VERBREITUNG IN DER EUROPÄISCHEN UNION. (German)
24 December 2021
0 references
C.RIVESTIN — DESARROLLO Y REGISTRO DE UN MEDICAMENTO DE USO HUMANO, PARA ENFERMEDADES RARAS: TRATAMIENTO DE LA CISTITIS INTERSTICIAL, POR SU DISTRIBUCIÓN EN LA UNIÓN EUROPEA. (Spanish)
25 January 2022
0 references
C.RIVESIN — UDVIKLING OG REGISTRERING AF ET HUMANMEDICINSK LÆGEMIDDEL TIL SJÆLDNE SYGDOMME: BEHANDLING AF INTERSTITAL BLÆREBETÆNDELSE, FOR DENS FORDELING PÅ DEN EUROPÆISKE UNION. (Danish)
5 July 2022
0 references
C.RIVESIN — ΑΝΆΠΤΥΞΗ ΚΑΙ ΚΑΤΑΧΏΡΙΣΗ ΦΑΡΜΆΚΟΥ ΓΙΑ ΑΝΘΡΏΠΙΝΗ ΧΡΉΣΗ, ΓΙΑ ΣΠΆΝΙΕΣ ΝΌΣΟΥΣ: ΘΕΡΑΠΕΊΑ ΤΗΣ ΜΕΣΟΣΤΕΙΑΚΉΣ ΚΥΣΤΊΤΙΔΑΣ, ΓΙΑ ΤΗΝ ΚΑΤΑΝΟΜΉ ΤΗΣ ΣΤΗΝ ΕΥΡΩΠΑΪΚΉ ΈΝΩΣΗ. (Greek)
5 July 2022
0 references
C.RIVESIN – RAZVOJ I REGISTRACIJA LIJEKA ZA HUMANU PRIMJENU, ZA RIJETKE BOLESTI: LIJEČENJE INTERSTITALNOG CISTITISA RADI NJEGOVE DISTRIBUCIJE U EUROPSKOJ UNIJI. (Croatian)
5 July 2022
0 references
C.RIVESIN – DEZVOLTAREA ȘI ÎNREGISTRAREA UNUI MEDICAMENT DE UZ UMAN, PENTRU BOLI RARE: TRATAMENTUL CISTITEI INTERSTITALE, PENTRU DISTRIBUIREA SA ÎN UNIUNEA EUROPEANĂ. (Romanian)
5 July 2022
0 references
C.RIVESIN – VÝVOJ A REGISTRÁCIA LIEKU NA HUMÁNNE POUŽITIE, NA ZRIEDKAVÉ CHOROBY: LIEČBA INTERSTITÁLNEJ CYSTITÍDY NA JEJ DISTRIBÚCIU V EURÓPSKEJ ÚNII. (Slovak)
5 July 2022
0 references
C.RIVESIN — ŻVILUPP U REĠISTRAZZJONI TA’ PRODOTT MEDIĊINALI GĦALL-UŻU MILL-BNIEDEM, GĦAL MARD RARI: TRATTAMENT TA’ ĊISTITE INTERSTITALI, GĦAD-DISTRIBUZZJONI TAGĦHA FL-UNJONI EWROPEA. (Maltese)
5 July 2022
0 references
C.RIVESIN — DESENVOLVIMENTO E REGISTO DE UM MEDICAMENTO PARA USO HUMANO, PARA DOENÇAS RARAS: TRATAMENTO DA CISTITE INTERSTITAL, PELA SUA DISTRIBUIÇÃO NA UNIÃO EUROPEIA. (Portuguese)
5 July 2022
0 references
C.RIVESIN – IHMISILLE TARKOITETUN LÄÄKKEEN KEHITTÄMINEN JA REKISTERÖINTI HARVINAISTEN SAIRAUKSIEN OSALTA: INTERSTITAALISEN KYSTIITIN HOITO SEN LEVITTÄMISEKSI EUROOPAN UNIONIIN. (Finnish)
5 July 2022
0 references
C.RIVESIN – OPRACOWANIE I REJESTRACJA PRODUKTU LECZNICZEGO STOSOWANEGO U LUDZI W LECZENIU RZADKICH CHORÓB: LECZENIE ŚRÓDMIĄŻSZOWEGO ZAPALENIA PĘCHERZA W CELU JEGO DYSTRYBUCJI W UNII EUROPEJSKIEJ. (Polish)
5 July 2022
0 references
C.RIVESIN – RAZVOJ IN REGISTRACIJA ZDRAVILA ZA UPORABO V HUMANI MEDICINI ZA REDKE BOLEZNI: ZDRAVLJENJE INTERSTITALNEGA CISTITISA ZA NJEGOVO PORAZDELITEV V EVROPSKI UNIJI. (Slovenian)
5 July 2022
0 references
C.RIVESIN – VÝVOJ A REGISTRACE HUMÁNNÍHO LÉČIVÉHO PŘÍPRAVKU PRO VZÁCNÁ ONEMOCNĚNÍ: LÉČBA INTERSTITÁLNÍ CYSTITIDY PRO JEJÍ DISTRIBUCI V EVROPSKÉ UNII. (Czech)
5 July 2022
0 references
C.RIVESIN – ŽMONĖMS SKIRTO VAISTO, SKIRTO RETOMS LIGOMS GYDYTI, KŪRIMAS IR REGISTRAVIMAS: INTERSTICINIO CISTITO GYDYMAS, JO PAPLITIMAS EUROPOS SĄJUNGOJE. (Lithuanian)
5 July 2022
0 references
C.RIVESIN — CILVĒKIEM PAREDZĒTU ZĀĻU IZSTRĀDE UN REĢISTRĀCIJA RETĀM SLIMĪBĀM: INTERSTICĀLA CISTĪTA ĀRSTĒŠANA, LAI TO IZPLATĪTU EIROPAS SAVIENĪBĀ. (Latvian)
5 July 2022
0 references
C.RIVESIN — РАЗРАБОТВАНЕ И РЕГИСТРАЦИЯ НА ЛЕКАРСТВЕН ПРОДУКТ ЗА ХУМАННА УПОТРЕБА, ЗА РЕДКИ ЗАБОЛЯВАНИЯ: ЛЕЧЕНИЕ НА ИНТЕРСТИТАЛЕН ЦИСТИТ, ЗА НЕГОВОТО РАЗПРОСТРАНЕНИЕ В ЕВРОПЕЙСКИЯ СЪЮЗ. (Bulgarian)
5 July 2022
0 references
C.RIVESIN – EMBERI FELHASZNÁLÁSRA SZÁNT GYÓGYSZER KIFEJLESZTÉSE ÉS TÖRZSKÖNYVEZÉSE RITKA BETEGSÉGEK ESETÉN: AZ INTERSTITÁLIS CYSTITIS KEZELÉSE AZ EURÓPAI UNIÓBAN VALÓ FORGALMAZÁSA CÉLJÁBÓL. (Hungarian)
5 July 2022
0 references
C.RIVESIN — TÁIRGE ÍOCSHLÁINTE LENA ÚSÁID AG AN DUINE A FHORBAIRT AGUS A CHLÁRÚ, I GCÁS GALAR NEAMHCHOITIANTA: AN CHAOI A GCAITEAR LE CISTÍTEAS IDIRCHATHRACH, CHUN É A DHÁILEADH AR AN AONTAS EORPACH. (Irish)
5 July 2022
0 references
C.RIVESIN – UTVECKLING OCH REGISTRERING AV HUMANLÄKEMEDEL FÖR SÄLLSYNTA SJUKDOMAR: BEHANDLING AV INTERSTITAL CYSTIT, FÖR DESS SPRIDNING I EUROPEISKA UNIONEN. (Swedish)
5 July 2022
0 references
C.RIVESIN – INIMTERVISHOIUS KASUTATAVATE HARULDASTE HAIGUSTE RAVIMI VÄLJATÖÖTAMINE JA REGISTREERIMINE: INTERSTIAALSE TSÜSTIIDI RAVI SELLE LEVIKUKS EUROOPA LIIDUS. (Estonian)
5 July 2022
0 references
MILANO
0 references
8 April 2023
0 references
Identifiers
E47F17001680002
0 references